@article{0738c0fae7ed4c7499d235a80a57d903,
title = "Janus kinases to jakinibs: from basic insights to clinical practice",
keywords = "cytokines, signal transduction, Janus kinases, kinase inhibitors, autoimmunity, inflammation, MODIFYING ANTIRHEUMATIC DRUG, COMBINED IMMUNE-DEFICIENCY, SELECTIVE JAK-1 INHIBITOR, RHEUMATOID-ARTHRITIS, INADEQUATE RESPONSE, TYROSINE KINASE, PRIMARY MYELOFIBROSIS, TRANSCRIPTION FACTORS, VX-509 DECERNOTINIB, DISEASE-ACTIVITY, 1182 Biochemistry, cell and molecular biology, 3121 General medicine, internal medicine and other clinical medicine",
author = "Massimo Gadina and Le, {Mimi T.} and Schwartz, {Daniella M.} and Olli Silvennoinen and Shingo Nakayamada and Kunihiro Yamaoka and O'Shea, {John J.}",
year = "2019",
month = feb,
doi = "10.1093/rheumatology/key432",
language = "English",
volume = "58",
pages = "4--16",
journal = "Rheumatology",
issn = "1462-0324",
publisher = "Oxford University Press",
}